Composition
| Ingredient | Strength |
|---|---|
| Glimepiride | 1 mg |
| Metformin Hydrochloride (prolonged release) | 500 mg |
Therapeutic use
Used in the management of type 2 diabetes mellitus. Glimepiride helps the pancreas release more insulin, while metformin reduces glucose production in the liver and improves insulin sensitivity.
For use under medical supervision only. Dosage, contraindications and precautions are as per the full prescribing information, available to registered medical practitioners on request.
Product details
- Brand name
- SUYGONE-M1™
- Therapy range
- Diabetic
- Dosage form
- Uncoated bilayered tablet
- Pack size
- 10 x 10 tablets
- Number of ingredients
- 2
- Marketed by
- Grori Pharma Pvt Ltd
Frequently asked questions
What is the composition of Suygone-M1?
Each unit of Suygone-M1 contains Glimepiride 1 mg + Metformin Hydrochloride (prolonged release) 500 mg.
What is Suygone-M1 used for?
Used in the management of type 2 diabetes mellitus. Glimepiride helps the pancreas release more insulin, while metformin reduces glucose production in the liver and improves insulin sensitivity.
Who markets Suygone-M1?
Suygone-M1 is marketed by Grori Pharma Pvt Ltd, Hyderabad, as part of its Diabetic range.
How can I get product information or place an order for Suygone-M1?
Doctors, pharmacies and distributors can call +91 95505 94814, +91 96528 45486 or +91 99669 45111, email groripharma@gmail.com, or use the enquiry form on the Grori Pharma contact page.